Stanford University CBCI-217
A Phase 1 Study of Nilotnib in Steroid Dependent / Refractory Chronic Graft Versus Host Disease.
X Study Closed
At Presbyterian/St. Luke's Medical Center
© 2016 HealthONE LLC All rights reserved
1721 East 19th Ave., Suite #200 & #300, Professional Plaza East / Presbyterian/St. Luke's Hospital, Denver, Colorado 80218
Phone 720.754.4800 • Fax 866.341.6984
Toll Free 1.877.268.9300